Medicine and Dentistry
Arm
9%
Contraindication
9%
Dysbiosis
100%
Escherichia
9%
Gastrointestinal Distress
9%
Glycon
100%
Gut
9%
Gut Microbiome
100%
Gut Microbiota
27%
Maturity Onset Diabetes of the Young
9%
Pathogen
18%
Peptostreptococcaceae
9%
Placebo
9%
Randomized Controlled Trial
9%
RNA 16S
9%
Shigella
9%
Side Effect
18%
Therapy Effect
9%
Volunteer
100%
Immunology and Microbiology
Arm
33%
Clostridiaceae
33%
Escherichia
33%
Gut Microbiome
100%
Infectious Agent
66%
Intestine Flora
100%
Normal Human
100%
Peptostreptococcaceae
33%
RNA Gene
33%
Shigella
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clostridiaceae
9%
Dysbiosis
100%
Gastrointestinal Symptom
9%
Infectious Agent
18%
Intestine Flora
27%
Metformin
100%
Microbiome
100%
Non Insulin Dependent Diabetes Mellitus
9%
Normal Human
100%
Peptostreptococcaceae
9%
Placebo
9%
Randomized Controlled Trial
9%
RNA 16S
9%
Shigella
9%
Side Effect
18%
Therapeutic Effect
9%
Tolerability
9%
Neuroscience
16S Ribosomal RNA
9%
Massive Parallel Sequencing
9%
Metformin
100%
Placebo
9%
Randomized Controlled Trial
9%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
33%